KG

Kamlesh Gupta

Active Director Director DIN 08817786
DIN 08817786 First appointment Aug 2020 Primary industry FMCG
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Kamlesh Gupta

Data last updated:

Kamlesh Gupta is a Director at Parivar Healthcare Private Limited (since 2020). The company operates in FMCG. Parivar Healthcare Private Limited reported revenue of ₹75.72 Cr (FY 2024).

DIN 08817786
Primary Designation Director
Industry FMCG
First Appointment 07 Aug 2020
Oldest Company Age 6 yrs
Largest company Parivar Healthcare Private Limited · ₹75.72 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Parivar Healthcare Private Limited U17299DL2020PTC367604
Director07 Aug 20202020₹75.72 Cr (FY 2024)Active

Board colleagues of Kamlesh Gupta

Directorship timeline

Open interactive timeline →
Parivar Healthcare Private Limited
Premium access

Shareholding and investment profile for Kamlesh Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamlesh Gupta

Kamlesh Gupta currently holds 1 directorship: Parivar Healthcare Private Limited (Director, since 07 Aug 2020, revenue ₹75.72 Cr (FY 2024)).

Kamlesh Gupta was first appointed on 07 Aug 2020 as Director at Parivar Healthcare Private Limited.

The current boards of Kamlesh Gupta's companies include Hemant Gupta (Parivar Healthcare Private Limited), Vijay Kumar Gupta (Parivar Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available